Incyte
INCY
$57.05
Share price
0.00%
Change (1 day)
-13.82%
Change (1 year)
Categories
Incyte (INCY) - Total assets
Total assets on the balance sheet as of March 2024 : $7.13 B
According to Incyte's latest financial reports the company's total assets are $7.13 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Incyte - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $6.78 B | 16.11% |
| 2022-12-31 | $5.84 B | 18.4% |
| 2021-12-31 | $4.93 B | 38.54% |
| 2020-12-31 | $3.56 B | 3.92% |
| 2019-12-31 | $3.42 B | 29.52% |
| 2018-12-31 | $2.64 B | 14.9% |
| 2017-12-31 | $2.30 B | 40.52% |
| 2016-12-31 | $1.63 B | 62.65% |
| 2015-12-31 | $1.00 B | 26.49% |
| 2014-12-31 | $0.79 B | 26.51% |
| 2013-12-31 | $0.62 B | 90.54% |
| 2012-12-31 | $0.33 B | 0.44% |
| 2011-12-31 | $0.32 B | -32.81% |
| 2010-12-31 | $0.48 B | -31.28% |
| 2009-12-31 | $0.71 B | 206.55% |
| 2008-12-31 | $0.23 B | -15.71% |
| 2007-12-31 | $0.27 B | -22.03% |
| 2006-12-31 | $0.35 B | -5.48% |
| 2005-12-31 | $0.37 B | -27.63% |
| 2004-12-31 | $0.51 B | 36.19% |
| 2003-12-31 | $0.37 B | -31.26% |
| 2002-12-31 | $0.55 B | -21.74% |
| 2001-12-31 | $0.70 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 1,222.02% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 3,074.23% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 796.12% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 1,261.54% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | -88.97% | 🇺🇸 USA |
 Geron GERN | $0.39 B | -94.48% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $0.11 B | -98.43% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $0.10 B | -98.58% | 🇺🇸 USA |
 Ardelyx ARDX | $0.29 B | -95.83% | 🇺🇸 USA |